Image For Activity Cover
Rare Bone Diseases

This module explores how to assess for and manage several rare bone diseases seen in endocrinology, including:  

  • Paget Disease  

  • Osteogenesis Imperfecta 

  • McCune-Albright Syndrome 

  • Hypophosphatemia 

  • Hypophosphatasia 

  • Albright Hereditary Osteodystrophy 

Each rare bone disease has a short video presentation from Dr. Sky Graybill, MD, that includes that includes in-video questions, followed by a quiz to test your knowledge and understanding of these diseases. Following these presentations and quiz, learners gain access to some additional resources to facilitate continued learning.  

Learning Objectives

Upon completing this activity, learners will better be able to: 

  • To understand the diagnosis, management, and treatment of Paget Disease 

  • To understand the diagnosis, management, and treatment of Osteogenesis Imperfecta 

  • To understand the diagnosis, management, and treatment of McCune-Albright Syndrome 

  • To understand the diagnosis, management, and treatment of Hypophosphatemia 

  • To understand the diagnosis, management, and treatment of Hypophosphatasia 

  • To understand the diagnosis, management, and treatment of Albright Hereditary Osteodystrophy 

Faculty and Disclosures

Sky Graybill, MD 
San Antonio Military Medical Center 

Reviewed and updated by the following members of the Fellows Training Series Workgroup: 

Bridget Sinnott, MD 
Medical College of Georgia 

Jeffrey Kroopnick, MD 
Eunice Kennedy Shrive National Institute of Child Health and Human Development 

Morali Sharma, MBBS, MD 
Kaiser Permanente - Oakland  

Marilyn Augustine, MD 
University of Rochester  


As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force. 


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The following faculty reported no relevant financial relationship: Sky Graybill, MD; Bridget Sinnott, MD; Jeffrey Kroopnick, MD; Morali Sharma, MBBS, MD; Marilyn Augustine, MD 

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships. 

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable. 

Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By